Shenda Hou

State Key Laboratory Of Cell Biology
Shanghai, 200031, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Correction: YAP Suppresses Lung Squamous Cell Carcinoma Progression via Deregulation of the DNp63-GPX2 Axis and ROS Accumulation.

Correction: YAP Suppresses Lung Squamous Cell Carcinoma Progression via Deregulation of the DNp63-GPX2 Axis and ROS Accumulation.

Journal: Cancer research

Published: October 02, 2021

Targeting HSPA1A in ARID2-deficient lung adenocarcinoma.

Targeting HSPA1A in ARID2-deficient lung adenocarcinoma.

Journal: National science review

Published: September 07, 2020

Branched-Chain Amino Acid Metabolic Reprogramming Orchestrates Drug Resistance to EGFR Tyrosine Kinase Inhibitors.

Branched-Chain Amino Acid Metabolic Reprogramming Orchestrates Drug Resistance to EGFR Tyrosine Kinase Inhibitors.

Journal: Cell reports

Published: June 18, 2018

FoxP3 and Ezh2 regulate Tfr cell suppressive function and transcriptional program.

FoxP3 and Ezh2 regulate Tfr cell suppressive function and transcriptional program.

Journal: The Journal of experimental medicine

Published: June 15, 2018

YAP Suppresses Lung Squamous Cell Carcinoma Progression via Deregulation of the DNp63-GPX2 Axis and ROS Accumulation.

YAP Suppresses Lung Squamous Cell Carcinoma Progression via Deregulation of the DNp63-GPX2 Axis and ROS Accumulation.

Journal: Cancer research

Published: February 17, 2017

Evidence, Mechanism, and Clinical Relevance of the Transdifferentiation from Lung Adenocarcinoma to Squamous Cell Carcinoma.

Evidence, Mechanism, and Clinical Relevance of the Transdifferentiation from Lung Adenocarcinoma to Squamous Cell Carcinoma.

Journal: The American journal of pathology

Published: September 29, 2016

Squamous Transition of Lung Adenocarcinoma and Drug Resistance.

Squamous Transition of Lung Adenocarcinoma and Drug Resistance.

Journal: Trends in cancer

Published: June 29, 2016

Evolution from genetics to phenotype: reinterpretation of NSCLC plasticity, heterogeneity, and drug resistance.

Evolution from genetics to phenotype: reinterpretation of NSCLC plasticity, heterogeneity, and drug resistance.

Journal: Protein & cell

Published: June 23, 2016

Showing 1-8 of 8

Last Updated: 09/26/2026